- Home
- LX vs SPRY Comparison
LX vs SPRY Comparison
Compare LX & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LX
- SPRY
- Stock Information
- Founded
- LX 2013
- SPRY 2015
- Country
- LX China
- SPRY United States
- Employees
- LX N/A
- SPRY N/A
- Industry
- LX Finance: Consumer Services
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- LX Finance
- SPRY Health Care
- Exchange
- LX Nasdaq
- SPRY Nasdaq
- Market Cap
- LX 1.3B
- SPRY 1.2B
- IPO Year
- LX 2017
- SPRY N/A
- Fundamental
- Price
- LX $7.79
- SPRY $13.44
- Analyst Decision
- LX
- SPRY Strong Buy
- Analyst Count
- LX 0
- SPRY 4
- Target Price
- LX N/A
- SPRY $28.75
- AVG Volume (30 Days)
- LX 2.8M
- SPRY 1.2M
- Earning Date
- LX 05-22-2025
- SPRY 05-14-2025
- Dividend Yield
- LX 2.34%
- SPRY N/A
- EPS Growth
- LX 2.93
- SPRY N/A
- EPS
- LX 0.89
- SPRY 0.08
- Revenue
- LX $1,945,937,716.00
- SPRY $89,149,000.00
- Revenue This Year
- LX $9.24
- SPRY $1.49
- Revenue Next Year
- LX $6.03
- SPRY $141.68
- P/E Ratio
- LX $9.07
- SPRY $168.31
- Revenue Growth
- LX 8.78
- SPRY 297063.34
- 52 Week Low
- LX $1.57
- SPRY $7.55
- 52 Week High
- LX $11.64
- SPRY $18.51
- Technical
- Relative Strength Index (RSI)
- LX 45.70
- SPRY 46.69
- Support Level
- LX $7.44
- SPRY $13.06
- Resistance Level
- LX $8.65
- SPRY $15.06
- Average True Range (ATR)
- LX 0.44
- SPRY 0.67
- MACD
- LX 0.09
- SPRY -0.18
- Stochastic Oscillator
- LX 50.86
- SPRY 15.97
About LX LexinFintech Holdings Ltd.
LexinFintech Holdings Ltd is an online consumer finance platform and a technology-driven service provider in China. The group is engaged in online direct sales services and online consumer finance services for its customers in the PRC. Geographically, it derives revenue from China.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.